---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-386662"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2026-09-09T21:37:25+00:00"
generated_at: "2026-09-10T10:05:54.374534+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical appoints former CEO David Bailey as Chief Commercial Officer

## Summary
- David Bailey named Chief Commercial Officer effective Sept 8, 2026; joins executive committee, reports to CEO Warren Foust.
- Bailey was STAAR CEO 2001-2008 and President Intl Ops 2008-2011; raised $60M+, secured 2005 FDA ICL approval, led Asia launches.
- Compensation: CHF 462,825 (~$575K) base, 60% target bonus, $850K RSU grant, $1.4M LTI award (50% options/50% RSUs).
- Return aims to accelerate EVO ICL growth as laser refractive volumes decline globally; expansion into South/Southeast Asia, South America, Africa.

## SEC filing metadata
- accession: 0001193125-26-386662
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2026-09-09T21:37:25+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/0001193125-26-386662-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000119312526386662/staa-20260909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-386662
- JSON: https://secwatch.observer/filing/0001193125-26-386662.json
- Plain text: https://secwatch.observer/filing/0001193125-26-386662.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.